Biomarker May Predict Treatment Outcome in Advanced Melanoma
Source: docwirenews, March 2021
Among patients receiving targeted therapy for advanced melanoma, BRAF V600-mutant cell-free circulating tumor DNA (ctDNA) measurements potentially could predict clinical outcome, according to a study published online Feb. 12 in The Lancet Oncology.
